Reaction
Hepatosplenic Candidiasis reporting signals
As of the last recalculation, Hepatosplenic Candidiasis appears in 146 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 359.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 26 | 359.7 | 360.5 |
| Thiotepa | 10 | 160.2 | 160.4 |
| Amikacin | 14 | 129.3 | 129.4 |
| Cytarabine | 39 | 125.9 | 126.0 |
| Posaconazole | 13 | 125.1 | 125.2 |
| Posaconazole Delayed-Release | 9 | 124.4 | 124.5 |
| Cefepime | 10 | 106.7 | 106.8 |
| Voriconazole Injection | 14 | 101.6 | 101.6 |
| Cefepime Hydrochloride | 10 | 94.9 | 95.0 |
| Micafungin Sodium | 5 | 87.0 | 87.1 |
| Busulfan | 9 | 86.8 | 86.9 |
| Voriconazole | 16 | 84.2 | 84.3 |